143 related articles for article (PubMed ID: 23100935)
1. Therapeutic efficacy of different types of platelet concentrates in thrombocytopenic patients.
Singh RP; Marwaha N; Malhotra P; Dash S
Indian J Hematol Blood Transfus; 2008 Mar; 24(1):16-22. PubMed ID: 23100935
[TBL] [Abstract][Full Text] [Related]
2. Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods.
Singh RP; Marwaha N; Malhotra P; Dash S
Asian J Transfus Sci; 2009 Jul; 3(2):86-94. PubMed ID: 20808653
[TBL] [Abstract][Full Text] [Related]
3. Quality assessment of platelet concentrates prepared by platelet-rich plasma, buffy-coat, and apheresis methods in a tertiary care hospital in South India: A cross-sectional study.
Toora E; Kulkarni RG; Manivannan P; Sastry AS; Basavarajegowda A; Sahoo D
Asian J Transfus Sci; 2023; 17(2):239-245. PubMed ID: 38274963
[TBL] [Abstract][Full Text] [Related]
4. Determination
Thuku NW; Shikuku K; Mbugua A
Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
[TBL] [Abstract][Full Text] [Related]
5. A Comparative Assessment of Quality of Platelet Concentrates Prepared by Buffy Coat Poor Platelet Concentrate Method and Apheresis Derived Platelet Concentrate Method.
Mallhi RS; Kumar S; Philip J
Indian J Hematol Blood Transfus; 2015 Dec; 31(4):453-9. PubMed ID: 26306070
[TBL] [Abstract][Full Text] [Related]
6. Comparative assessment of prophylactic transfusions of platelet concentrates obtained by the PRP or buffy-coat methods, in patients undergoing allogeneic hematopoietic stem cell transplantation.
Fernández-Muñoz H; Plaza EM; Rivera-Caravaca JM; Candela MJ; Romera M; De Arriba F; Lozano ML; Vicente V; Heras I; Castilla-Llorente C; Rivera J
Hematology; 2018 Oct; 23(9):712-718. PubMed ID: 29582705
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
[TBL] [Abstract][Full Text] [Related]
8. In-vivo evaluation of random donor platelet concentrates from pooled buffy coats.
Klüter H; Dörges L; Maass E; Wagner T; Bartels H; Kirchner H
Ann Hematol; 1996 Aug; 73(2):85-9. PubMed ID: 8774617
[TBL] [Abstract][Full Text] [Related]
9. Platelet concentrates from buffy coats: improved conditions for preparation and evaluation in routine clinical use.
Rebulla P; Bertolini F; Porretti L; Marangoni F; Smacchia C; Marconi M; Riccardi D; Sirelson V; Pappalettera M; Sirchia G
Transfus Sci; 1993 Jan; 14(1):41-6. PubMed ID: 10148312
[TBL] [Abstract][Full Text] [Related]
10. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
Akkök CA; Brinch L; Lauritzsen GF; Solheim BG; Kjeldsen-Kragh J
Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564
[TBL] [Abstract][Full Text] [Related]
11. Differences in levels of platelet-derived microparticles in platelet components prepared using the platelet rich plasma, buffy coat, and apheresis procedures.
Noulsri E; Udomwinijsilp P; Lerdwana S; Chongkolwatana V; Permpikul P
Transfus Apher Sci; 2017 Apr; 56(2):135-140. PubMed ID: 28029568
[TBL] [Abstract][Full Text] [Related]
12. Defining an appropriate leucoreduction strategy by serial assessment of cytokine levels in platelet concentrates prepared by different methods.
Kaur D; Sharma RR; Marwaha N
Asian J Transfus Sci; 2015; 9(1):31-5. PubMed ID: 25722570
[TBL] [Abstract][Full Text] [Related]
13. Paired comparison of platelet concentrates prepared from platelet-rich plasma and buffy coats using a new technique with 111In and 51Cr.
Keegan T; Heaton A; Holme S; Owens M; Nelson E; Carmen R
Transfusion; 1992 Feb; 32(2):113-20. PubMed ID: 1542917
[TBL] [Abstract][Full Text] [Related]
14. Pooled platelet concentrates: an alternative to single donor apheresis platelets?
Pietersz RN
Transfus Apher Sci; 2009 Oct; 41(2):115-9. PubMed ID: 19716340
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
Bertolini F; Rebulla P; Riccardi D; Cortellaro M; Ranzi ML; Sirchia G
Transfusion; 1989 Sep; 29(7):605-9. PubMed ID: 2773027
[TBL] [Abstract][Full Text] [Related]
16. Transfusion of platelet concentrates--clinical evaluation of two preparations.
Strindberg J; Berlin G
Eur J Haematol; 1996 Oct; 57(4):307-11. PubMed ID: 8982294
[TBL] [Abstract][Full Text] [Related]
17. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
Hitzler WE
Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
[TBL] [Abstract][Full Text] [Related]
18. Time Dependent Release of Interleukin-8 and Tumor Necrosis Factor-α in Platelet Concentrate.
Shukla RV; Patel TG; Gupte SC
Indian J Hematol Blood Transfus; 2015 Jun; 31(2):259-63. PubMed ID: 25825569
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions.
Anderson NA; Gray S; Copplestone JA; Chan DC; Hamon M; Prentice AG; Johnson SA; Phillips M; van Waeg G; Oakhill A; Abeyasekera S; Pamphilon DH
Transfus Med; 1997 Mar; 7(1):33-9. PubMed ID: 9089983
[TBL] [Abstract][Full Text] [Related]
20. Serial changes in morphology and biochemical markers in platelet preparations with storage.
Jain A; Marwaha N; Sharma RR; Kaur J; Thakur M; Dhawan HK
Asian J Transfus Sci; 2015; 9(1):41-7. PubMed ID: 25722572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
